Literature DB >> 7858893

Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.

A Zazpe1, I Artaiz, J Del Río.   

Abstract

1. The present study was aimed at examining the role of 5-HT3 receptors in basal and depolarization-evoked dopamine release from rat olfactory tubercle and striatal slices. [3H]-dopamine ([3H]-DA) release was measured in both brain regions and endogenous dopamine release from striatal slices was also studied. 2. The selective 5-HT3 receptor agonist 2-methyl-5-HT (0.5-10 microM) produced a concentration-dependent increase in [3H]-DA efflux evoked by K+ (20 mM) from slices of rat olfactory tubercle. 1-Phenylbiguanide (PBG) and 5-HT also increased K(+)-evoked [3H]-DA efflux. 3. 5-HT (1-100 microM) increased in a concentration-dependent manner basal [3H]-DA release from olfactory tubercle and striatal slices as well as endogenous DA release from striatal slices. The selective 5-HT3 receptor agonists 2-methyl-5-HT and 1-phenylbiguanide were weaker releasing agents. In all cases, the release was Ca2+ independent and tetrodotoxin insensitive. 4. 5-HT3 receptor antagonists such as ondansetron, granisetron and tropisetron (0.2 microM) significantly blocked the enhanced K(+)-evoked [3H]-DA efflux from rat olfactory tubercle slices induced by 2-methyl-5HT. A ten fold higher concentration of the 5-HT2 receptor antagonist ketanserin was ineffective. 5. Much higher concentrations, up to 50 microM, of the same 5-HT3 receptor antagonists did not block the increase in basal [3H]-DA release from striatal or olfactory tubercle slices induced by 5-HT or the release of endogenous DA induced by 5-HT from striatal slices.2+ off

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858893      PMCID: PMC1510446          DOI: 10.1111/j.1476-5381.1994.tb17087.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.

Authors:  R M Hagan; A Butler; J M Hill; C C Jordan; S J Ireland; M B Tyers
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

2.  Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.

Authors:  B Costall; A M Domeney; R J Naylor; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  The distribution of specific binding of the 5-HT3 receptor ligand [3H]GR65630 in rat brain using quantitative autoradiography.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Neurosci Lett       Date:  1988-11-22       Impact factor: 3.046

Review 4.  Cellular and molecular mechanisms of drug dependence.

Authors:  G F Koob; F E Bloom
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

5.  5-HT3 receptors are membrane ion channels.

Authors:  V Derkach; A Surprenant; R A North
Journal:  Nature       Date:  1989-06-29       Impact factor: 49.962

6.  Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.

Authors:  B Nurse; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1988-05       Impact factor: 3.996

Review 7.  Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.

Authors:  R M Hagan; G J Kilpatrick; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.

Authors:  L L Werling; A Frattali; P S Portoghese; A E Takemori; B M Cox
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

9.  Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons.

Authors:  S M Sorensen; T M Humphreys; M G Palfreyman
Journal:  Eur J Pharmacol       Date:  1989-04-12       Impact factor: 4.432

10.  Differences between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine and synthesis inhibition.

Authors:  H Herdon; J Strupish; S R Nahorski
Journal:  Brain Res       Date:  1985-12-02       Impact factor: 3.252

View more
  6 in total

Review 1.  Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Authors:  K D Alex; E A Pehek
Journal:  Pharmacol Ther       Date:  2006-10-17       Impact factor: 12.310

Review 2.  New perspectives in antiemetic treatment.

Authors:  J Herrstedt
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

3.  Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.

Authors:  S Body; K Asgari; J F Rickard; Z Zhang; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 4.  Presynaptic control of serotonin on striatal dopamine function.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Psychopharmacology (Berl)       Date:  2010-10-16       Impact factor: 4.530

5.  Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors.

Authors:  P De Deurwaerdère; L Stinus; U Spampinato
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

6.  5-HT3 Receptors in Rat Dorsal Root Ganglion Neurons: Ca2+ Entry and Modulation of Neurotransmitter Release.

Authors:  Katiuscia Martinello; Antonietta Sucapane; Sergio Fucile
Journal:  Life (Basel)       Date:  2022-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.